SCHEMBL26447355

SCHEMBL26447355

Oc1cccc2ccc3ccc4ccc(Cl)cc4c3c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.45
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
DNMT1 P26358 1/20 0.44
CACNA1B Q00975 1/20 0.44
APBA1 Q02410 1/20 0.44
MCL1 Q07820 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2A6 P11509 1/20 0.42
MAPT P10636 2/20 0.40
LMNA P02545 1/20 0.40
HSP90AA1 P07900 1/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 4/20 0.39
THRB P10828 2/20 0.39
HPGD P15428 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17792042 0.94 CHEK1 (0.46) CHEK1ALDH1A1MEN1KMT2ADNMT1
SCHEMBL4960994 0.84 CTDSP1 (0.59) ALDH1A1MEN1KMT2ACTDSP1CYP1A2
SCHEMBL19460401 0.81 CYP2A6 (0.47) ALDH1A1MEN1KMT2ADNMT1CACNA1B
SCHEMBL2467605 0.78 CYP1A2 (0.62) ALDH1A1MEN1KMT2ADNMT1CACNA1B
SCHEMBL26447356 0.78 ALDH1A1 (0.47) CHEK1ALDH1A1CYP1A2CYP2A6LMNA
SCHEMBL7126508 0.77 ALDH1A1 (0.59) ALDH1A1MEN1KMT2ADNMT1CACNA1B
SCHEMBL30887587 0.76 CYP2A6 (0.54) CHEK1ALDH1A1CYP1A2CYP2A6MAPK1
SCHEMBL1934750 0.76 CYP2A6 (0.54) CHEK1ALDH1A1CYP1A2CYP2A6MAPK1
SCHEMBL14742955 0.75 MCL1 (0.52) ALDH1A1MEN1KMT2ADNMT1CACNA1B
SCHEMBL17792040 0.73 ACHE (0.49) CHEK1ALDH1A1MEN1KMT2ACYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230140483-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-04 US disclosed
US-20230140483-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230140483-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OR10J3 CHEK1 3560/4885ALDH1A1 66/4885MEN1 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.